Intracardiac Echocardiography for Procedural Guidance of Left Atrial Appendage Occlusion From Right Atrium: A Subgroup From a Multicenter Randomized Controlled Trial With Two Intracardiac Echocardiography Imaging Systems.
The DynaSight ICE system has the same clear image quality as the SoundStar, which-guided LAAO with the catheter in right atrium is intraprocedural effective and safe for device implantation.
Abstract
Background
Intracardiac echocardiography (ICE)-guided left atrial appendage occlusion (LAAO) from left atrium under local anesthesia showed potential advantages over transesophageal echocardiography (TOE). This study sought to demonstrate the intraprocedural efficiency and safety of LAAO with ICE guidance in right atrium.
Methods
In a multicenter randomized controlled trial to assess whether the imaging quality of a novel DynaSight ICE system (SONOSEMI, Shenzhen, China) is noninferior to the SoundStar (Biosense Webster, USA), a sub-group analysis was performed in patients who underwent LAAO under local anesthesia with ICE guidance in right atrium.
Results
Thirty-three of 66 in the DynaSight group and 30 of 67 in the SoundStar group were performed LAAO with ICE guidance in right atrium. There were no statistical differences between two groups in baseline characteristics including demographics, cardiovascular comorbidities, CHA2DS2-VASc score, and HAS-BLED score. Both ICE systems had similar clear image qualities according to multi-plane assessments for home view, atrial septum and left atrium, and judgments for occluders including displaying location and resolution. There was comparable procedural successful rate for device implantation (100% in the DynaSight group vs. 96.67% in the SoundStar group, p = 0.4762) and occurrence of major peri-procedural complications including tamponade, device embolism, death, major bleeding, and ischemic stroke/transient ischemic attack/systemic embolism (0 of 33 in the DynaSight group vs. 3 of 30 in the SoundStar group, p = 0.1022).
Conclusions
The DynaSight ICE system has the same clear image quality as the SoundStar, which-guided LAAO with the catheter in right atrium is intraprocedural effective and safe for device implantation.
This meta-analysis indicates that ICE is a safe, effective, and non-inferior alternative to TEE for patients undergoing AF ablation ± LAAC, however, TEE remains an effective tool for detecting LAA thrombus.
M. Dandamudi, B. Hakkeem, Juan Pinilla et al.· European Heart Journal-Cardi...· 0 citations
BACKGROUND
Persistent iatrogenic atrial septal defect (iASD) is a known consequence of transseptal puncture (TSP). Large-bore double transseptal access through a single TSP is commonly used for intracardiac echocardiography (ICE)-guided left atrial appendage occlusion (LAAO). This study evaluated the incidence and clin...
K. Culler, Aamir Ahmed, Supreet Singh et al.· Journal of interventional ca...· 0 citations
Background/Objectives: Cardioembolic sources account for a substantial minority of ischemic strokes, and in non-valvular atrial fibrillation nearly all left atrial thrombi form in the left atrial appendage (LAA). We asked whether extending a standard CT stroke protocol caudally to cover the LAA would add diagnostic yie...
Kaitlyn E. Heintzelman, Enrique M. Carrera, Katherine Burkhardt et al.· Hearts· 0 citations
EFT1, the EFT volume immediately adjacent to the left atrium, is strongly associated with LAAT, and the novel nomogram integrating EFT1, LAAV, and the CHA2DS2‐VA score provides enhanced risk stratification for thrombotic and prethrombotic states in patients with AF.
En-Yuan Zhang, Xiaoyan Wu, Feng-Min Lu et al.· Cardiology Research and Prac...· 0 citations
Abstract Aims In severe rheumatic mitral stenosis (MS) with sinus rhythm, left atrial appendage (LAA) dysfunction increases thromboembolic risk, yet clinical guidelines provide no recommendations, and its assessment via transoesophageal echocardiography is not feasible for routine or repeated use. This study assessed w...
J. Yusuf, Gaurav Sharma, Ankit Bansal et al.· European Heart Journal Open· 0 citations
TTE is recommended as the first-line CRAT screening tool for MHD patients and combined TTE and DSA use improves diagnostic yield, and regular targeted surveillance for high-risk individuals reduces CRAT incidence.
Fen Yu, Xiaomei Huang, Jing-Jing Liu et al.· Journal of Clinical Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.